Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Abbott launches real-time remote neuromodulation tech

March 8, 2021 By Nancy Crotti

Abbott NeuroSphere Virtual Clinic

(Image courtesy of Abbott)

Abbott (NYSE:ABT) announced today that the FDA has approved a neuromodulation treatment platform that allows physicians to communicate with patients and monitor or change their treatment in real-time.

The NeuroSphere Virtual Clinic could increase access to treatment for patients with chronic pain or movement disorders who don’t live close to a care provider, have difficulty accessing care, or are unable to go to the doctor because of circumstances like COVID-19, according to the company.

The NeuroSphere Virtual Clinic provides a secure in-app video chat and an integrated remote programming feature within the company’s Patient Controller app, which gained FDA approval in July 2020. NeuroSphere enables clinicians to prescribe new treatment settings remotely to the patient’s neurostimulation device using its Clinician Programmer app. It is compatible with these systems from Abbott:

  • Infinity deep-brain stimulation (DBS) system for patients with Parkinson’s disease and tremors of the upper extremities in adults with essential tremors.
  • Proclaim XR spinal-cord stimulation (SCS) system for patients living with chronic pain of the trunk and/or limbs.
  • Proclaim dorsal root ganglion (DRG) neurostimulation system for patients with chronic pain in the lower limbs caused by complex regional pain syndrome or causalgia.

“This is a significant advancement for chronic pain patients,” said Dr. Timothy Deer, president & CEO of The Spine and Nerve Center of the Virginias in Charleston, W.Va., in a news release from Abbott.

“NeuroSphere Virtual Clinic solves considerable issues patients with movement disorders, such as Parkinson’s disease or essential tremor, can have in obtaining the care they need,” added Dr. Drew Falconer, neurologist and director of the Inova Parkinson’s and Movement Disorders Center in Fairfax, Va. “Often, patients must be off their medication overnight, so that their treatments can be adjusted properly, which can make it difficult for a patient to travel to their specialist. With NeuroSphere Virtual Clinic, patients can receive stimulation settings from their physicians in real-time and remotely via cloud and Bluetooth-based technology, which is something we have never been able to do before. This opens up a world in which patients can receive the care they need anytime, anywhere.”

Patients would need to have a cellular or Wi-Fi connection and a sufficiently charged Patient Controller, the company noted. Medicare will cover remote programming services as a telehealth benefit through the duration of the public health emergency.

On average, people living with movement disorders will travel over 150 miles to reach specialists offering DBS, according to Abbott’s own data. Without alternative solutions, such as digital and/or telehealth options, these patients are more likely to delay or forego care, according to a recent study by Deloitte.

“A decade ago, we started evaluating the hurdles that patients had to overcome to receive neuromodulation treatment, and we have been working ever since to find a better way to connect providers and patients – with the goal of empowering patients to decide how to access
the care they need,” said Abbott neuromodulation VP Keith Boettiger. “We are continuing to make these kinds of investments and working with regulatory authorities to make these telehealth changes permanent, as we believe that patients should be able to receive the care they need, regardless of whether they can make it physically to the doctor’s office.”

Related Articles Read More >

Min-Vasive Medtech: Live interviews and audience Q&As with minimally invasive engineers from Edwards Lifesciences, Jupiter Endo and Compremium
PrecisionX Group buys Hudson Technologies
PSN Labs expands ISO 13485 certification to design and development
DIVA Labs announces imaging product developments
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe